These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Increased INR after gefitinib and acenocoumarol co-administration. Ribed A; Escudero-Vilaplana V; Gonzalez-Haba E; Sanjurjo M Eur Rev Med Pharmacol Sci; 2014; 18(12):1720-2. PubMed ID: 24992614 [TBL] [Abstract][Full Text] [Related]
25. Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment. Gschwind L; Rollason V; Boehlen F; Rebsamen M; Combescure C; Grünenwald M; Matthey A; Bonnabry P; Dayer P; Desmeules JA Pharmacogenomics; 2013 May; 14(7):745-53. PubMed ID: 23651023 [TBL] [Abstract][Full Text] [Related]
26. Is it safe to perform joint infiltrations or aspirations in patients anticoagulated with acenocoumarol? Guillen Astete C; Boteanu A; Medina Quiñones C; Garcia Montes N; Roldan Moll F; Carballo Carmano C; Zea Mendoza A Reumatol Clin; 2015; 11(1):9-11. PubMed ID: 24891041 [TBL] [Abstract][Full Text] [Related]
27. INR variability in anticoagulation with acenocoumarol: is it useful for identifying patients at risk of bleeding and thrombosis? Casais P; Sánchez Luceros A; Meschengieser S; Bermejo E; Lazzari MA Haematologica; 1999 Aug; 84(8):753-4. PubMed ID: 10457416 [No Abstract] [Full Text] [Related]
28. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon. Beinema M; Brouwers JR; Schalekamp T; Wilffert B Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230 [TBL] [Abstract][Full Text] [Related]
29. Interaction of acenocoumarol and sitaxentan in pulmonary arterial hypertension. Pulido T; Sandoval J; Roquet I; Gutiérrez R; Rueda T; Peña H; Santos E; Miranda MT; Lupi E Eur J Clin Invest; 2009 Jun; 39 Suppl 2():14-8. PubMed ID: 19335742 [TBL] [Abstract][Full Text] [Related]
30. [Increased INR from concomitant use of acenocoumarol and capecitabine]. Tomlow B; Voll ML; Smorenburg CH Ned Tijdschr Geneeskd; 2012; 156(26):A4793. PubMed ID: 22759711 [TBL] [Abstract][Full Text] [Related]
31. Acenocoumarol stabilization is delayed in CYP2C93 carriers. Schalekamp T; van Geest-Daalderop JH; de Vries-Goldschmeding H; Conemans J; Bernsen Mj Mj; de Boer A Clin Pharmacol Ther; 2004 May; 75(5):394-402. PubMed ID: 15116052 [TBL] [Abstract][Full Text] [Related]
32. Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users. Verhoef TI; Redekop WK; Buikema MM; Schalekamp T; Van Der Meer FJ; Le Cessie S; Wessels JA; Van Schie RM; De Boer A; Teichert M; Visser LE; Maitland-Van Der Zee AH; J Thromb Haemost; 2012 Apr; 10(4):606-14. PubMed ID: 22252093 [TBL] [Abstract][Full Text] [Related]
33. Acenocoumarol is not a safe alternative for anticoagulation in phenprocoumon-induced hepatic failure. Report of two cases. Neef M; Kerekes Z; Fischer HP; Sauerbruch T; Spengler U Digestion; 2003; 67(1-2):100-4. PubMed ID: 12743448 [TBL] [Abstract][Full Text] [Related]
34. Switching from acenocoumarol to warfarin in patients with unstable anticoagulation and its effect on anticoagulation control. Undas A; Cieśla-Dul M; Zółciński M; Tracz W Pol Arch Med Wewn; 2009 Jun; 119(6):360-5. PubMed ID: 19694217 [TBL] [Abstract][Full Text] [Related]
35. Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort. Maagdenberg H; Bierings MB; van Ommen CH; van der Meer FJM; Appel IM; Tamminga RYJ; de Boer A; Maitland-van der Zee AH J Thromb Haemost; 2018 Jan; 16(1):116-124. PubMed ID: 29108090 [TBL] [Abstract][Full Text] [Related]
37. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic. Ghaswalla PK; Harpe SE; Tassone D; Slattum PW Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199 [TBL] [Abstract][Full Text] [Related]
38. Acute renal failure caused by severe coagulopathy induced by the interaction between warfarin potassium and levofloxacin: a case report. Nemoto C; Ikegami Y; Shimada J; Tsukada Y; Abe Y; Tase C J Anesth; 2012 Dec; 26(6):943-4. PubMed ID: 22875515 [No Abstract] [Full Text] [Related]
39. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol]. Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670 [TBL] [Abstract][Full Text] [Related]